Effect of screening and adjuvant therapy on mortality from breast cancer.

By D. Berry, Kathleen A. Cronin, Sylvia K. Plevritis, Dennis G. Fryback, L. Clarke, M. Zelen, J. Mandelblatt, Andrei Yakovlev, J. Dik F. Habbema, E. Feuer. New England Journal of Medicine, 2006

1,479 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology

View Paper: https://www.semanticscholar.org/paper/046f7a5da5450f02bfddcc51f61e2803d9329e9f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. R. Siegel
2. A. Jemal
3. K. Miller
4. K. J. Chavez
5. W. Foulkes
6. S. Garimella
7. S. Lipkowitz

In Oncology

1. A. Jemal
2. R. Siegel
3. K. Miller
4. Elizabeth E. Ward
5. C. DeSantis
6. Jiemin Ma
7. S. Fedewa
8. Julia H. Rowland

Citations in the corpus

• Cancer treatment and survivorship statistics, 2014 (2014, background): “This increase is due largely to improvements in treatment (ie, chemotherapy, hormone therapy, and targeted drugs) and to earlier diagnosis as a result of the widespread use of mammography for breast cancer screening.(23) The 10-year and 15-year relative survival rates for breast cancer are 83.”
• Breast cancer statistics, 2017, racial disparity in mortality by state (2017, background): “Declines in breast cancer mortality rates have been attributed to both improvements in treatment (eg, adjuvant chemotherapy and hormonal therapy in the 1980s and targeted therapies in the 1990s) and early detection by mammography.(30,31) Not all women have benefited equally from these improvements, ”
• Breast cancer statistics, 2011 (2011, background): “Declines in breast cancer mortality have been attributed to both improvements in treatment and early detection.(16)”
• Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival (2017, background): “Modeling studies suggest that both screening and adjuvant therapy contributed to declines in breast cancer mortality (73).”
• Annual Report to the Nation on the Status of Cancer, 1975–2006, Featuring Colorectal Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates (2010, background): “frequently diagnosed cancer and the second leading cause of cancer death among women, already is recommended for women.(61) Breast cancer incidence also has fluctuated with increases and decreases over time (Table 1) but declined 1.”
• Annual Report to the Nation on the Status of Cancer, 1975–2012, Featuring the Increasing Incidence of Liver Cancer (2016, neutral): “Advances in treatment and early detection contribute to the ongoing decrease in breast cancer mortality among women overall.(65) However, not all racial and ethnic groups benefit equally in this favorable trend: black women have a higher breast cancer death rate than white women.”
• The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. (2012, positive): “Studies from different parts of the world have indicated that the improvements in survival for breast cancer patients have been driven by a combination of earlier diagnosis (due to mammographic screening of asymptomatic women) and advances in treatment [11, 86, 87], although the extent of the contri”
• Breast Cancer Statistics (2013, background): “In this chapter, we review the female breast cancer burden in the United States focusing on incidence and mortality and their temporal trends by race/ethnicity, along with an overview of global burden of this disease.”
• Is Breast Cancer the Same Disease in Asian and Western Countries? (2010, background): “, the input of each contributed about equally to improved breast cancer outcomes [39].”